Health Insurance AI in India: A Governance Checklist for Claims and Underwriting Teams

Begin with the decision the workflow is allowed to support

Claims triage, document completeness checks, duplicate-submission review, case summarisation, underwriting preparation and portfolio analysis are different workflows. Each has a different purpose, evidence threshold, reviewer role and impact on a policyholder. Write down the proposed input, output, user, decision owner and what the system must never do before assessing a supplier.

A flag can help a reviewer decide where to look; it is not proof of fraud, non-disclosure, clinical inappropriateness or an exclusion. Likewise, a health risk indicator can describe a defined estimate for a stated population and time horizon, but it is not a diagnosis or a general judgement about a person. Do not make a model output the sole basis for a premium, coverage, underwriting or claim decision.

Make consent, purpose and source boundaries visible

Health and claims information should not be treated as a generic data pool. Map every source—proposal information, claims documents, hospital records, laboratory results, a personal health record or an ABDM-related exchange—to its permitted purpose, approved recipient, collection path, retention rule and correction process. The Digital Personal Data Protection Act, 2023 establishes a framework for processing digital personal data for lawful purposes, while its commencement is tied to government notification. Teams should confirm the rules and obligations applicable to their specific workflow with qualified privacy and legal advisers.

IRDAI’s health-insurance FAQ states that an insurer may facilitate ABHA creation with the policyholder’s specific consent, and that express consent is required for sharing medical records or related information in every instance. Treat that as an operational design requirement: display the purpose, do not use an identifier as blanket permission, and record the event that allowed the particular exchange. Participation, available records and connected systems can vary.

• Name the member-facing purpose in plain language before requesting or receiving data
• Keep source, date, completeness and any transformation visible to authorised reviewers
• Limit access to the role and case that need it, rather than sharing a broad longitudinal record by default
• Provide an appropriate route to correct a factual record or raise a concern about its use

Design claims support around evidence, not automatic rejection

A claims workflow can use automation to group documents, surface a missing field, compare submitted information with defined rules or prioritise a queue for review. It needs clear stop points. When the outcome could affect payment, coverage or access to a benefit, an authorised reviewer should see the relevant source material, the reason a case was surfaced, uncertainty or conflicts, and the policy or process that applies.

Test false positives and false negatives with representative, appropriately governed cases. A high-volume pattern can still be harmful if it repeatedly routes a particular type of claimant to unnecessary delay or treats a document-quality issue as a substantive finding. Keep the final rationale, evidence considered and reviewer identity in the case record. IRDAI’s policyholder-protection framework should inform the customer journey; it is not replaced by a new analytics interface.

Use underwriting assistance carefully

Underwriting tools can prepare a structured summary, highlight missing information or make a reviewer aware of a declared condition that needs clarification. They should not invent health facts, infer sensitive characteristics from unrelated data or silently apply a changing rule set. The authorised insurance professional remains responsible for using the correct product terms, evidence and applicable process.

Before a pilot, define the intended population and question, the decision that remains human, the sources that are allowed, the intervention when data are missing, and the appeal or challenge route. Compare the tool’s output with an independent human review. Check whether its performance, calibration and error patterns differ across relevant groups or channels. A model that is not understood, monitored and reversible is not ready for a consequential workflow.

Require explainability, challenge and operational resilience

Explainability is not necessarily a technical disclosure of every model parameter. It means an authorised reviewer can understand what the output was intended to do, which source material and factors it relied on, what was missing, how current the information is and when the output should be ignored. A policyholder-facing process also needs an appropriate way to seek clarification, correct data and challenge a decision through the insurer’s established channels.

Treat the workflow as an insurance and information-security operation, not just a software feature. IRDAI’s information and cyber-security guidance makes insurers responsible for ensuring adequate mechanisms where policyholder information is shared with regulated entities and other intermediaries. Review access control, supplier roles, audit logs, incident handling, exports, configuration changes, business continuity and a safe fallback if the tool is unavailable.

A practical procurement and pilot checklist

Ask a supplier to demonstrate a real, governed case flow with representative documents and the people who will use it: claims operations, medical reviewers, underwriting, privacy, security, customer service and compliance. A generic scorecard is less useful than a traceable walk-through from permitted input to human decision, communication and correction route.

• What precise task does the system support, and which adverse or consequential decisions is it prohibited from making?
• Can the reviewer trace each material flag or summary statement to a dated source and see missing or conflicting information?
• How are member permission, purpose, role-based access, retention and withdrawal or correction events recorded?
• Who approves rule and model changes, and can the organisation reproduce the version used in a past case?
• How are accuracy, calibration, delays, false flags and disparate outcomes measured before and during use?
• Can the organisation export the case record, explain the workflow and operate safely when the tool or a connected source is unavailable?